Vernalis PLC Regulatory News (VER)

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Vernalis Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

Placing & Open Offer

X

3. Full name of person(s) subject to the notification obligation:

GlaxoSmithKline plc

4. Full name of shareholder(s) (if different from 3.):

GlaxoSmithKline LLC (formerly known as SmithKline Beecham Corporation)

5. Date of the transaction and date on which the threshold is crossed or reached:

02 March 2010

6. Date on which issuer notified:

29 March 2010

7. Threshold(s) that is/are crossed or reached:

3%

8. Notified details:

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

Ordinary 1p Shares

2,040,542

2,040,542

2,040,542

2,040,542

2.05%

 GB00B3Y5L754

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

None

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date

Exercise/ Conversion period

Number of voting rights instrument refers to

% of voting rights

None

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

2,040,542

2.05%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

N/A

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

The change in shareholding is due to the Placing & Open Offer approved by shareholders at a General Meeting on 1 March 2010, which resulted in an increase in the Total Voting Rights figure to 99,571,509.

14. Contact name:

 David Mackney, CFO

15. Contact telephone number:

0118 989 9360